On September 9, 2022 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported that will host a conference call and simultaneous webcast to share updates on the company’s oncology portfolio in conjunction with the European Society for Medical Oncology (ESMO) (Free ESMO Whitepaper) Annual Congress on Monday, September 12, 2022 (Press release, Regeneron, SEP 9, 2022, View Source [SID1234619325]). The webcast is scheduled for 8:00 AM ET (2:00 PM CEST) and may be accessed from the "Investors & Media" page of Regeneron’s website at View Source To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the webcast will be archived on the Company’s website for at least 30 days.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!